Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

BPM31510 Administered Intravenously With Gemcitabine in Advanced Pancreatic Cancer Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02650804
Recruitment Status : Completed
First Posted : January 8, 2016
Last Update Posted : September 16, 2020
Sponsor:
Information provided by (Responsible Party):
Berg, LLC

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : June 11, 2019
Actual Study Completion Date : June 11, 2019
Certification/Extension First Submitted : September 14, 2020